Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
drugs
fda
life sciences
national blog main
acute hepatic porphyrias
akin akinc
alnylam pharmaceuticals
aminolevulinic acid
boston
boston blog main
boston top stories
cannabidiol
dravet syndrome
epidiolex
fen-phen
fenfluramine
givosiran
gw pharmaceuticals
lennox-gastaut syndrome
onpattro
patisiran
paul matteis
rna interference
san francisco
san francisco blog main
san francisco top stories
stifel financial
zogenix
What
ago
2
×
drug
fda
medicine
pharmaceuticals
2
×
weeks
alnylam
approval
approved
battle
cannabis
data
derivative
epilepsy
form
gw
gw’s
indicated
interference
marijuana
market
nod
quick
rare
rna
rnai
second
seek
sets
speedy
won’t
zogenix
Language
Current search:
pharmaceuticals
×
ago
×
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug
